At present, China's pharmaceutical equipment products are exported to over 85 countries, with an average annual growth rate of 23.075% in total delivery value. All eight categories of products are exported, and the number of engineering contracting projects continues to increase. With the continuous improvement of drug quality standards, the demand for pharmaceutical machinery in China is constantly expanding. While the total output value of the domestic pharmaceutical machinery industry has grown significantly, a large number of foreign-funded enterprises have also entered. Domestic and foreign-funded enterprises have formed a competitive and close combat situation. In the future, the domestic pharmaceutical machinery industry will focus on improving standards, enhancing self-discipline, and continuously improving core competitiveness.
Experts have pointed out that "after ten years of high-speed growth, enterprises have begun to shift towards a period of moderate growth. In the process of adapting to industry changes, enterprises need to strengthen industry self-discipline, regulate market competition, and abandon bad habits that are not conducive to industry development. Only in this way can it be conducive to the healthy and sustainable development of the industry
Zyzhan believes that a company needs to have its own characteristics and strength. There are two models: one is to expand marketing and strengthen service growth through internal sources, and the other is to achieve leapfrog development through mergers and acquisitions. Once upon a time, the booming Chinese construction machinery market attracted many foreign companies to participate, and their expansion methods were accompanied by localization of production and sales.
